Stock INDSWFTLAB IND-SWIFT LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Ind-Swift Laboratories Limited Bombay S.E.

Equities

INDSWFTLAB

INE915B01019

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 06:00:50 2024-04-26 am EDT 		5-day change 1st Jan Change
124.8 INR +0.29% Intraday chart for Ind-Swift Laboratories Limited +5.35% +20.05%
Apr. 19 Ind-Swift Laboratories to Incorporate Wholly-Owned Arm in Dubai MT
Apr. 19 Ind-Swift Laboratories Limited Announces Incorporation of Wholly Owned Subsidiary CI

Business Summary

Ind-Swift Laboratories Limited is an India-based company. The Company is engaged in the business of manufacturing intermediates and formulations. The Company’s products or services include Advanced Intermediates. It is API partner for many organizations both in generic and innovative domains. The Company offers reference standards and impurities for various active pharmaceutical ingredients (APIs) under British Pharmacopoeia (BP), European Pharmacopoeia (EP), British Pharmacopoeia (BP) and others. Its impurity portfolio is stocked with a range of standards for supply. The Company offers reference standards and impurities for over 25 APIs. All impurities are shipped with full documentation, including a Certificate of Analysis and MSDS. The research center, spread over the area of 40,000 square feet, is engaged in developing process technology for APIs in different therapeutic categories.

Number of employees: 1,496

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceuticals - Manufactured
99.6 %
10,375 99.9 % 12,029 99.6 % +15.94%
Pharmaceuticals - Traded
0.4 %
11 0.1 % 44 0.4 % +297.99%
Services
0.0 %
1 0.0 % 0 0.0 % -67.69%

Sales per region

INR in Million2022Weight2023Weight Delta
International
77.6 %
7,960 76.6 % 9,374 77.6 % +17.76%
India
22.4 %
2,427 23.4 % 2,699 22.4 % +11.22%

Managers

Managers TitleAgeSince
Navrattan Munjal CEO
 Chief Executive Officer 72 95-01-03
Himanshu Jain CEO
 Chief Executive Officer 41 -
Gagan Aggarwal DFI
 Director of Finance/CFO - 18-09-28
Vijay Singla COO
 Chief Operating Officer 49 -
Pardeep Verma CMP
 Compliance Officer - -
Lalit K. Wadhwa COO
 Chief Operating Officer - 11-06-15
Varun Chhabra SAM
 Sales & Marketing - -
Ashok Prasad PRN
 Corporate Officer/Principal - -
Anurag Chaturvedi SAM
 Sales & Marketing - -
Vikas Narendra PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Himanshu Jain CEO
 Chief Executive Officer 41 -
Navrattan Munjal CEO
 Chief Executive Officer 72 95-01-03
Sri Prakash Sharma BRD
 Director/Board Member 68 09-08-30
Rishav Mehta BRD
 Director/Board Member 33 10-03-22
Ashwani Kumar Vig BRD
 Director/Board Member 74 14-12-30
Neerja Chathley BRD
 Director/Board Member 69 19-05-09
Sahil Munjal BRD
 Director/Board Member 43 20-02-12
Rajinder Kumar Gupta BRD
 Director/Board Member 67 21-06-22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 59,086,918 19,416,499 ( 32.86 %) 0 32.86 %

Shareholders

NameEquities%Valuation
IND-SWIFT LIMITED
37.79 %
22,327,507 37.79 % 26 M ₹
Ashok Kumar Chandak
3.402 %
2,010,219 3.402 % 2 M ₹
Navrattan Munjal
1.558 %
920,724 1.558 % 1 M ₹
Sri Ganesh Biotech Pvt Ltd.
1.347 %
796,006 1.347 % 938 189 ₹
Conquer Investment & Finance Pvt Ltd.
1.180 %
697,055 1.180 % 821 563 ₹
Edelweiss Alternative Asset Advisors Ltd.
0.9377 %
554,040 0.9377 % 653 003 ₹
Rishav Mehta
0.7693 %
454,545 0.7693 % 535 736 ₹
Himanshu Jain
0.6888 %
406,961 0.6888 % 479 652 ₹
Neera Mehta
0.4214 %
249,000 0.4214 % 293 476 ₹
Sanjeev Rai Mehta
0.3954 %
233,600 0.3954 % 275 326 ₹

Company contact information

Ind-Swift Laboratories Ltd.

SCO 850, Shivalik Enclave NAC

160101, Manimajra

+91 17 2506 1850

http://www.indswiftlabs.com
address Ind-Swift Laboratories Limited(INDSWFTLAB)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sales per region

Sector Generic Pharmaceuticals

1st Jan change Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.62% 43.34B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.44% 21.96B
SANDOZ GROUP AG Stock Sandoz Group AG
+10.86% 14.09B
CIPLA LIMITED Stock Cipla Limited
+13.07% 13.64B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+37.46% 11.43B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.59% 6.86B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+8.46% 5.22B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. INDSWFTLAB Stock
  4. INDSWFTLAB Stock
  5. Company Ind-Swift Laboratories Limited